672927-26-3

Basic information

• Product Name: 1-Piperidinecarboxylic acid, 4-(4-chlorophenyl)-4-(hydroxymethyl)-, 1,1-dimethylethyl ester
• CAS NO: 672927-26-3
• Molecular Formula: C17H24ClNO3
• Molecular Weight: 325.835
• Mol File: 672927-26-3.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: 1-Piperidinecarboxylic acid, 4-(4-chlorophenyl)-4-(hydroxymethyl)-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Piperidinecarboxylic acid, 4-(4-chlorophenyl)-4-(hydroxymethyl)-, 1,1-dimethylethyl ester(672927-26-3)
• EPA Substance Registry System: 1-Piperidinecarboxylic acid, 4-(4-chlorophenyl)-4-(hydroxymethyl)-, 1,1-dimethylethyl ester(672927-26-3)

Safety Data

• Hazardous Substances Data: 672927-26-3(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 672927-27-4 [4-(4-chloro-phenyl)-piperidin-4-yl]-methanol 
• 849106-01-0 4-(4-chloro-phenyl)-piperidine-1,4-dicarboxylic acid 1-tert-butyl ester 4-methyl ester 
• 140-53-4 p-chlorobenzyl cyanide 
• 118753-70-1 N-(tert-butyloxycarbonyl)bis(2-chloroethyl)amine 
• 218451-34-4 4-(4-chloro-phenyl)-4-cyano-piperidine-1-carboxylic acid tert-butyl ester 
• 644981-94-2 4-(4-chloro-phenyl)-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester 

Downstream Products

• 885500-46-9 tert-butyl 4-(4-chlorophenyl)-4-formylpiperidine-1-carboxylate 
• 1146362-73-3 tert-butyl 4-(4-chlorophenyl)-4-methoxymethylpiperidine-1-carboxylate 
• 672927-27-4 [4-(4-chloro-phenyl)-piperidin-4-yl]-methanol 

Relevant articles and documents

ACYL SULFONAMIDE NAV1.7 INHIBITORS

The present disclosure relates to compounds of formula I which inhibit NaV1.7, and include pharmaceutically acceptable salts, compositions comprising such compounds, and methods using and making such compounds and compositions. (I)

CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF

Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: or physiologically acceptable salt thereof.

SUBSTITUTED PIPERAZINO-DIHYDROTHIENOPYRIMIDINES

The invention relates to new piperidino-dihydrothienopyrimidines of formula 1, as well as pharmacologically acceptable salts thereof, wherein X is SO or SO2, but preferably SO, and wherein R1, R2, R3 and R4 may have the meanings given in claim 1, as well as pharmaceutical compositions which contain these compounds. These new piperidino-dihydrothienopyrimidines are suitable for the treatment of respiratory or gastrointestinal complaints or diseases, inflammatory diseases of the joints, skin or eyes, diseases of the peripheral or central nervous system or cancers.